When insomnia treatment has not helped: what to review next

When insomnia continues despite treatment, the next step is a careful review rather than automatically buying a more intensive programme. The important questions are what was assessed, what treatment was actually delivered, whether it was suitable and tolerable, and which parts of the problem remain unexplained.

Persistent symptoms do not establish that recovery is impossible, that you did something wrong, or that residential care is necessary. They show that the current plan deserves another look. This guide offers a framework for preparing that review and comparing recommendations without interpreting a difficult treatment experience as a personal failure.

Define what has and has not changed

Describe the original problem and the current pattern separately. You might fall asleep more easily but still wake early. You may remain tired during the day even though the night feels less distressing. Another person may have fewer difficult nights but still avoid travel because of fear about sleep.

These distinctions matter when discussing the response. A single overall statement such as “nothing worked” can hide partial changes and unresolved symptoms. Write down the details without trying to decide whether the treatment should count as a success.

Include any worsening or new concerns. Report unintended sleep episodes, unusual mood changes, breathing symptoms, or troubling medication effects. New information may alter the assessment question rather than simply justify continuing the same approach for longer.

Make an accurate record of previous treatment

List each intervention, who provided it, the intended purpose, approximate duration, and what happened. Separate general advice, relaxation content, medication, structured insomnia therapy, and treatment for another condition. This is an inventory, not a judgement about the value of every experience.

For a programme described as CBT-I, ask what components were delivered and how they were reviewed. The term should not be assumed to cover any form of counselling or sleep coaching. AASM guidance supports a specific multicomponent approach for chronic insomnia, rather than sleep hygiene alone. AASM guideline.

Bring relevant letters or reports where available. Avoid repeating a complete assessment simply because information is scattered between services. With your consent, a coordinating clinician can request the material needed to understand what has already been done.

Revisit the original assessment

Ask whether the working diagnosis still fits. Explain changes in sleep timing, daytime functioning, medical history, medicines, and circumstances since the initial appointment. A plan made before a major change may need reassessment rather than stricter adherence.

The review should consider whether there is enough opportunity for sleep and whether another sleep problem needs investigation. Relevant questions include breathing concerns, significant daytime sleepiness, unusual night-time events, and a pattern closely tied to work or travel schedules. NHLBI: insomnia diagnosis.

Ask the clinician to identify what is established and what remains uncertain. A useful review can acknowledge uncertainty while specifying how it will be addressed. Avoid accepting a confident new label simply because it sounds more sophisticated than the previous one.

Separate practical barriers from treatment failure

A programme may have been difficult to use because of caring duties, unpredictable shifts, mobility limitations, language, cost, or limited access to support. Explain these barriers directly. They are part of the clinical context, not evidence that you lacked motivation.

Ask which components were feasible and which were not. A therapist may need to adapt the plan or recommend a different delivery format. Do not retrospectively claim that you followed every instruction if the actual experience was more complicated; accurate information is more useful than appearing compliant.

Also describe adverse or unsafe effects. Significant sleepiness, mood changes, or difficulties performing essential tasks deserve review. You should not be required to persist with an unsafe approach in order to prove that the treatment received a fair trial.

Review medication with the responsible prescriber

Bring a complete list of medicines and substances, including what you actually used. Describe benefit, side effects, changes in dose or frequency, and concerns about supply. Ask whether the original treatment goal is still relevant and who is coordinating future decisions.

Do not abruptly stop a regularly used benzodiazepine because another treatment has disappointed you. Sudden discontinuation or rapid reduction can cause serious withdrawal. A prescriber should develop and monitor any change according to the individual situation. FDA benzodiazepine safety.

Avoid stacking new products on top of old ones while waiting for review. A list of several sleep aids can make the pattern harder to interpret and introduce additional risks. Ask for one coordinated plan rather than collecting separate prescriptions or recommendations from services that do not communicate.

Consider overlapping mental-health and medical needs

Anxiety, depression, trauma-related symptoms, pain, and other conditions may need their own assessment alongside insomnia. This does not mean the sleep problem is merely secondary or should be ignored until everything else improves. Ask how the care plan addresses the relevant concerns together.

Prepare examples from daytime life and explain which symptoms feel most disruptive. If several professionals are involved, ask who is responsible for integrating their recommendations. A referral is useful only when the receiving service understands the question it is being asked to answer.

A major reduction in need for sleep accompanied by unusual energy or behavioural change needs prompt clinical attention. Do not assume it is a welcome improvement in insomnia. Describe the change plainly and seek advice from the treating team rather than waiting for the next routine therapy appointment.

Decide whether another opinion would be useful

A second opinion can be helpful when the assessment remains unclear, the plan is poorly explained, or the proposed next step is substantial. Prepare records and specific questions so the consultation can address the uncertainty rather than restart from an incomplete history.

Ask the new clinician what they agree with, what they would reconsider, and why. Different opinions should be compared by reasoning and evidence, not by which offers the strongest guarantee. Be cautious about a service that dismisses every previous professional without reviewing the actual records.

Clarify how ongoing care will be handed over or coordinated. Two incompatible plans can create confusion, especially around medication. Choose a clear route for clinical responsibility before making changes based on separate consultations.

Evaluate proposed tests and intensive programmes

For any additional test, ask what question it answers and how the result changes care. More measurements can produce more information without resolving the practical problem. A broad commercial panel should not be presented as a necessary gateway to all treatment.

For residential care, ask what clinical needs justify living on site and what cannot reasonably be delivered as outpatient care. A stay may have a role in a broader assessed presentation, but persistent insomnia alone is not a sufficient explanation of that role.

Request a written proposal covering assessment, treatment, specialist access, emergency arrangements, exclusions, cost, and follow-up. A beautiful setting or long list of activities does not establish that the unresolved sleep problem has been understood. Read outpatient versus residential care before committing.

Agree a revised plan and a review point

At the end of the review, ask for three things: the updated working explanation, the specific next action, and the date or condition for reassessment. Identify the person responsible for each step. This prevents “try something else” becoming a sequence of disconnected experiments.

Choose outcomes that describe both sleep and daily life. Ask how to report problems and what should prompt earlier contact. Keep the plan manageable enough that you can explain it to another clinician without relying on a collection of contradictory leaflets.

A useful revised plan may be less dramatic than a new label or expensive programme. It could involve better coordination, a different delivery format, an appropriate investigation, or a clearer medication review. The important point is the reasoned connection between the problem and the proposed response.

Questions people often ask

Does needing another review mean CBT-I cannot help me?

Not necessarily. Review what was delivered, how it was adapted, and what remains unresolved. Only the treating professional can interpret the individual experience. Avoid deciding that every possible form of treatment has been exhausted because one programme was unhelpful.

Should I wait until the insomnia becomes unbearable?

No. Request a review when symptoms persist, functioning remains affected, or the plan creates concerns. New safety issues deserve prompt attention. You do not need to demonstrate a crisis to justify asking whether the current approach still fits.

What should I send to a new provider?

Start with a concise summary, relevant reports, a medication list, and the questions you need answered. Confirm a secure clinical channel before sharing detailed records. A marketing enquiry should establish the next conversation, not collect your entire health history without a clear purpose.

Prepare a concise treatment timeline

Create a short record of each approach, the dates or approximate period, what you were asked to do, and what changed. Include why it stopped: lack of benefit, side effects, practical difficulty, cost, or a recommendation from the clinician. These are different reasons and may lead to different next steps.

Avoid describing every previous intervention simply as a failure. A course that was interrupted by illness or delivered without the expected support is not the same as a fully reviewed treatment that did not help. Equally, do not minimise substantial effort you have already made.

Bring the timeline to the next assessment and ask which parts are most informative. It can help prevent unnecessary repetition and show where a different question needs investigating. The goal is a more precise next decision, not accumulating an ever longer list of treatments to try without a coherent plan.

Sources

AASM guideline; NHLBI: diagnosis; FDA: benzodiazepine safety.